Potent induction of IFN-γ production from cord blood NK cells by the stimulation with Single-Stranded RNA

Journal of Clinical Immunology

Volumn 31, Issue 4, 2011, Pages 728-735

  Eljaafari, Fairuz Mohamed ^a   Takada, Hidetoshi ^a   Tanaka, Tamami ^a   Doi, Takehiko ^a   Ohga, Shouichi ^a   Hara, Toshiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Cord blood; IFN ; Innate immunity; Natural killer cells

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; INTERLEUKIN 2; SINGLE STRANDED RNA; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; ADULT; AGE DISTRIBUTION; ARTICLE; CELL ACTIVITY; CELL FUNCTION; CELL STIMULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HOST RESISTANCE; HUMAN; HUMAN CELL; INNATE IMMUNITY; MONOCYTE; NATURAL KILLER CELL; NEWBORN; NEWBORN PERIOD; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; UMBILICAL CORD BLOOD; VIRUS INFECTION;

ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CULTURE MEDIA; CYTOTOXICITY, IMMUNOLOGIC; FETAL BLOOD; HUMANS; INTERFERON-ALPHA; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-2; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LEUKOCYTES, MONONUCLEAR; RNA; TOLL-LIKE RECEPTOR 8;

EID: 80555150836     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-011-9528-4     Document Type: Article

References (45)

1. Lewis DB, Wilson CB. Developmental immunology and role of host defenses in fetal and neonatal susceptibility to infection. In: Klein JO, Remington JS, Wilson CB, Baker CJ, editors. Infectious diseases of the fetus and newborn infant. 6th ed. Philadelphia: Elsevier Saunders; 2006. p. 25-138.
2. Levy O. Innate immunity of the newborn: Basic mechanisms and clinical correlates. Nat Rev Immunol. 2007;7:379-90. (Pubitemid 46674489)
3. Wu J, Lanier LL. Natural killer cells and cancer. Adv Cancer Res.2003;90:127-56. (Pubitemid 37549223)
4. Etzioni A, Eidenschenk C, Katz R, et al. Fatal varicella associated with selective natural killer cell deficiency. J Pediatr.2005;146:423-5. (Pubitemid 40341757)
5. Biron CA. Initial and innate responses to viral infections: Pattern setting in immunity or disease. Curr Opin Microbiol. 1999;2:374-81. (Pubitemid 29366958)
6. Martin-Fontecha A, Thomsen LL, Brett S, et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for TH1 priming. Nat Immunol. 2004;5:1260-5. (Pubitemid 41057741)
7. Hart OM, Athie-Morales V, O'Connor GM, et al. TLR7/8- mediated activation of human NK cells results in accessory celldependent IFN-? production. J Immunol. 2005;175:1636-42. (Pubitemid 41023066)
8. Hornung V, Rothenfusser S, Britsch S, et al. Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol. 2002;168:4531-7. (Pubitemid 34441357)
9. Sivori S, Falco M, Della Chiesa M, et al. CpG and doublestranded RNA trigger human NK cells by Toll-like receptors: Induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc Natl Acad Sci USA. 2004;101:10116-21. (Pubitemid 38891204)
10. Alexopoulou L, Holt AC, Medzhitov R, et al. Recognition of double-stranded RNA and activation of NF-B by Toll-like receptor 3. Nature. 2001;413:732-8. (Pubitemid 33009951)
11. Takeshita F, Leifer CA, Gursel I, et al. Cutting edge: Role of Tolllike receptor 9 in CpG DNA-induced activation of human cells. J Immunol. 2001;167:3555-8. (Pubitemid 32910795)
12. Gorden KB, Gorski KS, Gibson SJ, et al. Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8. J Immunol. 2005;174:1259-68.
13. Welte S, Kuttruff S, Waldhauer I, et al. Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction. Nat Immunol. 2006;7:1334-42. (Pubitemid 46111255)
14. Dalbeth N, Gundle R, Davies RJ, et al. CD56bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation. J Immunol. 2004;173:6418-26. (Pubitemid 39487802)
15. Hamerman JA, Ogasawara K, Lanier LL. Cutting edge: Toll-like receptor signaling in macrophages induces ligands for the NKG2D receptor. J Immunol. 2004;172:2001-5. (Pubitemid 38182343)
16. Biron CA, Nguyen KB, Pien GC, et al. Natural killer cells in antiviral defense: Function and regulation by innate cytokines. Annu Rev Immunol. 1999;17:189-220. (Pubitemid 29241123)
17. Schmidt KN, Leung B, Kwong M, et al. APC-independent activation of NK cells by the Toll-like receptor 3 agonist double-stranded RNA. J Immunol. 2004;172:138-43. (Pubitemid 38020465)
18. Okamura H, Tsutsui H, Komatsu T, et al. Cloning of a new cytokine that inducesIFN-? production by T cells. Nature (Lond).1995;378:88-91.
19. Ushio S, Namba M, Okura T, et al. Cloning of the cDNA for human IFN-?-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J Immunol. 1996;156:4274-9. (Pubitemid 26165826)
20. Klein JO, Baker CJ, Remington JS, et al. Current concepts of infections of the fetus and newborn infant. In: Klein JO, Remington JS, Wilson CB, Baker CJ, editors. Infectious diseases of the fetus and newborn infant. 6th ed. Philadelphia: Elsevier Saunders; 2006. p. 1-24.
21. Siegrist CA. Mechanisms underlying adverse reactions to vaccines. J Comp Pathol. 2007;137:S46-50.
22. Alford CA, Stagno S, Pass RF, et al. Congenital and perinatal cytomegalovirus infections. Rev Infect Dis. 1990;7:S745-53. (Pubitemid 20311816)
23. Preblud SR, Bregman DJ, Vernon LL. Deaths from varicella in infants. Pediatr Infect Dis J. 1985;4:503-7. (Pubitemid 15019916)
24. Ogra PL. Respiratory syncytial virus: The virus, the disease and the immune response. Paediatr Respir Rev. 2004;5:S119-26.
25. Bottino C, Moretta L, Pende D, et al. Learning how to discriminate between friends and enemies, a lesson from natural killer cells. Mol Immunol. 2004;41:569-75. (Pubitemid 38824614)
26. Biron CA, Nguyen KB, Pien GC. Innate immune responses to LCMV infections: Natural killer cells and cytokines. Curr Top Microbiol Immunol. 2002;263:7-27. (Pubitemid 34183854)
27. Orange JS, Biron CA. An absolute and restricted requirement for IL-12 in natural killer cell IFN-? production and antiviral defense: Studies of natural killer and T cell responses in contrasting viral infections. J Immunol. 1996;156:1138-42.
28. Byrne P, McGuirk P, Todryk S, et al. Depletion of NK cells results in disseminating lethal infection with Bordetella pertussis associated with a reduction of antigen-specific Th1 and enhancement of Th2, but not Tr1 cells. Eur J Immunol. 2004;34:2579-88. (Pubitemid 39302815)
29. Bancroft GJ. The role of natural killer cells in innate resistance to infection. Curr Opin Immunol. 1993;5:503-10. (Pubitemid 23250287)
30. Biron CA, Byron KS, Sullivan JL. Severe herpes virus infections in an adolescent without natural killer cells. N Engl J Med.1989;320:1731-5. (Pubitemid 19163129)
31. Becker I, Salaiza N, Aguirre M, et al. Leishmania lipophosphoglycan (LPG) activates NK cells through Toll-like receptor-2. Mol Biochem Parasitol. 2003;130:65-74. (Pubitemid 37289124)
32. Stark GR, Kerr IM, Williams BR, et al. How cells respond to interferons. Annu Rev Biochem. 1998;67:227-64. (Pubitemid 28411130)
33. Nguyen KB, Watford WT, Salomon R, et al. Critical role for STAT4 activation by type 1 interferons in the interferon-? response to viral infection. Science. 2002;297:2063-6.
34. Guidotti LG, Chisari FV. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol.2001;19:65-91. (Pubitemid 32368030)
35. Price DA, Klenerman P, Booth BL, et al. Cytotoxic T lymphocytes, chemokines and antiviral immunity. Immunol Today.1999;20:212-6. (Pubitemid 29217076)
36. McCarron M, Reen DJ. Activated human neonatal CD8+ T cells are subject to immunomodulation by direct TLR2 or TLR5 stimulation. J Immunol. 2009;182:55-62.
37. Levy O, Zarember KA, Roy RM, et al. Selective impairment of TLR-mediated innate immunity in human newborns: Neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848. J Immunol. 2004;173:4627-34. (Pubitemid 39280696)
38. Levy O, Suter EE, Miller RL, et al. Unique efficacy of Toll-like receptor 8 agonists in activating human neonatal antigenpresenting cells. Blood. 2006;108:1284-90. (Pubitemid 44232026)
39. Gibson SJ, Lindh JM, Riter TR, et al. Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod. Cell Immunol. 2002;218:74-86. (Pubitemid 36027092)
40. Fehniger TA, Shah MH, Turner MJ, et al. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: Implications for the innate immune response. J Immunol. 1999;162:4511-20. (Pubitemid 29314849)
41. Nomura A, Takada H, Jin CH. Functional analyses of cord blood natural killer cells and T cells: A distinctive interleukin-18 response. Exp Hematol. 2001;29:1169-76. (Pubitemid 32927217)
42. Satwani P, Ayello J, Ven C, et al. Immaturity of IL-18 gene expression and protein production in cord blood (CB) versus peripheral blood (PB) mononuclear cells and differential effects in natural killer (NK) cell development and function. Br J Haematol. 2005;130:284-92. (Pubitemid 41602530)
43. Aste-Amezaga M, D'Andrea A, Kubin M, et al. Cooperation of natural killer cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cellassociated molecules in human T and NK cells. Cell Immunol.1994;156:480-92. (Pubitemid 24252901)
44. Gerosa F, Gobbi A, Zorzi P, et al. The reciprocal interaction of NK cells with plasmacytoid or myeloiddendritic cells profoundly affects innate resistance functions. J Immunol. 2005;174:727-34. (Pubitemid 40094266)
45. Draghi M, Pashine A, Sanjanwala B, et al. NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection. J Immunol. 2007;178:2688-98. (Pubitemid 46333145)